Gore Launches New 7.5 cm Length GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface

New device size comes in response to physicians’ requests for additional offerings to expand treatment options

Gore has released a new 7.5-centimeter length of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface. Gore developed this size in response to physician needs for certain clinical situations. The GORE VIABAHN Endoprosthesis is now available in six lengths: 2.5, 5, 7.5, 10, 15 and 25 cm. (Photo: Business Wire)

FLAGSTAFF, Ariz.--()--W. L. Gore & Associates (Gore) today announced the availability of a new 7.5 centimeter length of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface. Gore developed this size in response to physician needs for certain clinical situations. The GORE VIABAHN Endoprosthesis is now available in six lengths: 2.5, 5, 7.5, 10, 15 and 25 cm.

The GORE VIABAHN Endoprosthesis is the lowest profile, most flexible, self-expanding stent-graft available. In 2013, the Food and Drug Administration (FDA) granted indication for the GORE VIABAHN Endoprosthesis to treat stenosis or thrombotic occlusion at the venous anastomosis of synthetic arteriovenous access grafts. The flexibility of the device allows placement across the elbow and other challenging venous anastomotic locations.

“Selecting the right length device is an important part of getting good outcomes for dialysis access patients. Until now, some cases required choosing between stacking two devices or unnecessarily covering healthy tissue,” said John Ross, MD, Dialysis Access Institute, Orangeburg Regional Medical Center, Orangeburg, SC. “The new 7.5 cm length Viabahn [GORE VIABAHN Endoprosthesis] improves the ability to land the device with the most accuracy."

“Gore is committed to enhancing our device offerings to meet the demands of a rapidly-evolving healthcare market,” said Ben Beckstead, PhD, Clinical and Technical Peripheral Interventional Business Unit Leader. “Through continued engagement with our physician partners, we identified a significant clinical need for an intermediate-length device. We believe this new offering will help physicians provide better patient care.”

For more information about the GORE VIABAHN Endoprosthesis please visit, http://www.goremedical.com/viabahn/.

ABOUT US

At Gore Medical, we have provided creative therapeutic solutions to complex medical problems for 40 years. During that time, 40 million innovative Gore Medical Devices have been implanted, saving and improving the quality of lives worldwide. Our extensive family of products includes vascular grafts, endovascular and interventional devices, surgical meshes for hernia and soft tissue reconstruction, staple line reinforcement materials, and sutures for use in vascular, cardiac, and general surgery. We are one of a select few companies to appear on all of the U.S. “100 Best Companies to Work For” lists since the rankings debuted in 1984. For more information, visit www.goremedical.com.

GORE®, VIABAHN®, and designs are trademarks of W. L. Gore & Associates.

Contacts

Chempetitive Group for W. L. Gore & Associates
Andrea Vuturo, +1-312-997-2436
GoreMedical@Chempetitive.com

Release Summary

Gore releases new 7.5-centimeter length of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface. Gore developed this size in response to physician needs for certain clinical situations.

Contacts

Chempetitive Group for W. L. Gore & Associates
Andrea Vuturo, +1-312-997-2436
GoreMedical@Chempetitive.com